58 studies found for:    Open Studies | "Papilloma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Papilloma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Conditions: Breast Discharge Infected;   Intraductal Papilloma of Breast
Intervention: Device: Ductoscopic papillomectomy
2 Recruiting The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
Conditions: Flat Epithelia Atypia;   Intraductal Papilloma Without Atypia
Intervention: Other: Pathologic evaluation of excised tissue
3 Unknown  e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
Conditions: Cervical Cancer;   Human Papilloma Virus Infection
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
4 Recruiting Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City
Condition: Human Papilloma Virus
Intervention: Biological: quadrivalent human papillomavirus (types 6, 11, 16,18) recombinant vaccine
5 Recruiting The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)
Conditions: Human Papilloma Virus;   Oropharyngeal Squamous Cell Carcinoma
Interventions: Procedure: PET/CT;   Radiation: Radiotherapy;   Radiation: Concurrent Chemoradiation
6 Not yet recruiting A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
Condition: Human Papilloma Virus
Interventions: Drug: bivalent HPV vaccine;   Drug: nonavalent HPV vaccine
7 Not yet recruiting Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
Conditions: Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs
Interventions: Drug: Alisertib;   Drug: TAK-228
8 Recruiting Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: Pembrolizumab
9 Recruiting 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Radiation: fludeoxyglucose F 18;   Radiation: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
10 Unknown  Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Condition: Papilloma Viral Infection
Intervention:
11 Recruiting Phase II Evaluation of AHCC for the Eradication of HPV Infections
Conditions: Human Papilloma Virus;   Dysplasia;   CIN1;   CIN2
Interventions: Dietary Supplement: AHCC 3 grams once a day;   Other: Placebo
12 Recruiting HPV-test, Cervical Cancer and Follow-up
Conditions: Human Papilloma Virus;   Uterine Cervical Neoplasms;   Recurrence
Intervention: Procedure: Human Papilloma Virus test from the vaginal vault
13 Unknown  Text Reminders to Immunize in a Managed Care Organization
Condition: Human Papilloma Virus
Interventions: Other: Text-based reminder for recommended HPV vaccine or well care visit;   Other: Non-specific text-based reminder (general health tip)
14 Unknown  Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China
Conditions: Human Papilloma Virus;   Cervical Cancer;   Cervical Intraepithelial Neoplasia
Intervention:
15 Recruiting The HPV Self-test as a Test of Cure in Madagascar
Conditions: Human Papilloma Virus Infection;   Cervical Intraepithelial Neoplasia Grade 2/3
Intervention: Device: HPV test
16 Recruiting Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)
Condition: Human Papilloma Virus Infection
Interventions: Other: First-void urine collection;   Other: Blood draw
17 Recruiting Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: carboplatin;   Radiation: radiation therapy;   Drug: paclitaxel;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
18 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
19 Recruiting Community-Driven Cervical Cancer Prevention in Western Kenya
Conditions: Human Papilloma Virus Infection;   Carcinoma in Situ of Uterine Cervix
Interventions: Behavioral: Community-based testing with standard linkage to care;   Behavioral: Community-based HPV testing with enhanced linkage to care
20 Recruiting Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Verrucous Carcinoma of the Larynx
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: intensity-modulated radiation therapy;   Procedure: quality-of-life assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years